Journey Medical Corp [DERM] stock prices are up 2.00% to $7.14 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The DERM shares have gain 9.68% over the last week, with a monthly amount drifted -9.28%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Journey Medical Corp [NASDAQ: DERM] stock has seen the most recent analyst activity on August 22, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $9. On December 07, 2021, B. Riley Securities initiated with a Buy rating and assigned a price target of $14 on the stock.
The stock price of Journey Medical Corp [DERM] has been fluctuating between $3.54 and $8.25 over the past year. Currently, Wall Street analysts expect the stock to reach $10.5 within the next 12 months. Journey Medical Corp [NASDAQ: DERM] shares were valued at $7.14 at the most recent close of the market. An investor can expect a potential return of 47.06% based on the average DERM price forecast.
Analyzing the DERM fundamentals
The Journey Medical Corp [NASDAQ:DERM] reported sales of 56.24M for trailing twelve months, representing a surge of 0.84%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.15%, and Net Profit Margin reading is -0.15%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.52 and Total Capital is -0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.98 points at the first support level, and at 6.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.25, and for the 2nd resistance point, it is at 7.37.
Ratios To Look Out For
It’s worth pointing out that Journey Medical Corp [NASDAQ:DERM]’s Current Ratio is 1.34. On the other hand, the Quick Ratio is 1.03, and the Cash Ratio is 0.52. Considering the valuation of this stock, the price to sales ratio is 2.96, the price to book ratio is 7.66.
Transactions by insiders
Recent insider trading involved Maraoui Claude, President & CEO, that happened on May 02 ’25 when 4834.0 shares were sold. CFO, Benesch Joseph completed a deal on May 02 ’25 to sell 2409.0 shares. Meanwhile, COO Alloush Ramsey sold 2857.0 shares on May 02 ’25.
